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Objectives: The naturally occurring polyphenol (2)-epicatechin gallate (ECg) increases oxacillin
susceptibility in mecA-containing strains of Staphylococcus aureus. Decreased susceptibility to lyso-
staphin suggests alterations to the wall teichoic acid (WTA) content of ECg-grown bacteria. Changes in
WTA structure in response to ECg were determined.
Methods: Nuclear magnetic resonance spectroscopy of purified monomers from S. aureus was used to
elucidate WTA structures. Molecular modelling of WTA chains was employed to determine their spatial
configuration.
Results: ECg-grown methicillin-resistant S. aureus (MRSA) strains BB568 and EMRSA-16 displayed
markedly reduced resistance to oxacillin, had thickened cell walls and separated poorly. Growth in
ECg-supplemented medium reduced the substitution of the WTA backbone by D-alanine (D-Ala); ratios
of N-acetyl glucosamine to D-Ala were reduced from 0.6 and 0.49 (for BB568 and EMRSA-16) to 0.3 and
0.28, respectively. Molecular simulations indicated a decrease in the positive charge of the bacterial
wall, confirmed by increased binding of cationized ferritin, and an increase in WTA chain flexibility to a
random coil conformation.
Conclusions: Structural elucidation and molecular modelling of WTA indicated that conformational
changes associated with reduced D-Ala substitution may contribute to the increased susceptibility of
MRSA to b-lactam antibiotics and account for other elements of the ECg-induced phenotype.
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Introduction
The steady rise in the incidence of infections due to
Staphylococcus aureus resistant to second-generation b-lactam
antibiotics such as methicillin and flucloxacillin [methicillin-
resistant S. aureus (MRSA) strains] and their impact on treatment
have been well documented.1,2 Therapeutic options are further
compromised by the tendency of staphylococci to accumulate
genes conferring resistance to a range of non-b-lactam agents.
Galloyl catechins, naturally occurring polyphenolic constituents of
green tea,3 have the capacity to reduce penicillin binding protein
2a (PBP2a)-mediated b-lactam resistance4 and to disrupt the
secretion of virulence-related proteins, such as coagulase and
a-toxin,5 by S. aureus. These abundant secondary metabolites
could offer a much-needed alternative approach to the treatment of
intractable infections caused by MRSA and related pathogens.
Following growth in medium containing either (2)-epigallocate-
chin gallate or (2)-epicatechin gallate (ECg), MRSA strains are
sensitized to the bactericidal action of a wide range of b-lactam
agents.4 The non-galloyl equivalents (2)-epigallocatechin and
(2)-epicatechin are unable to modulate the levels of b-lactam
resistance, but have the capacity to potentiate galloyl catechin-
mediated sensitization.6 ECg, the most potent b-lactam modifier,
and other catechins interact with lipid bilayers via hydrophobic
domains7–9 and their capacity to reduce b-lactam resistance corre-
lates closely with their degree of penetration into the phospholipid
palisade.6 Galloyl catechins also promote cell wall thickening and
cell aggregation,10 reduce slime production and inhibit the
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formation of staphylococcal biofilms.11,12 ECg does not suppress
transcription of mecA or production of its product, PBP2a; sensit-
ization to b-lactam antibiotics is due to a more complex and
incompletely defined mechanism.12 The polyphenol elicits some
changes in the levels of PBPs 1 and 3 in the staphylococcal
membrane, resulting in a 5% to 10% reduction in peptidoglycan
cross-linking; this modification is insufficient to compromise cell
integrity.12 In addition, ECg promotes retention of autolysins,
enzymes that play a key role in cell separation and peptidoglycan
turnover in the cell wall, probably in a predominantly inactive
form.12
Lysostaphin is a peptidoglycan hydrolase that cleaves pentagly-
cine cross-bridges between glycan strands within peptidoglycan.13
Growth of MRSA in broth supplemented with ECg markedly
decreases susceptibility to lysostaphin.12 Peptidoglycan–wall tei-
choic acid (WTA) complexes extracted from cells grown in
ECg-supplemented medium are less susceptible to lysostaphin
hydrolysis than complexes from bacteria grown in non-
supplemented medium; after removal of WTA, rates of peptidogly-
can hydrolysis by lysostaphin were essentially identical, regardless
of the source of substrate.12 These data suggest that ECg induces
alterations in the composition, structure or conformation of WTA;
these poly-D-ribitol-phosphate wall components14 are known to
affect methicillin susceptibility.15 In order to shed light on the mol-
ecular basis of the b-lactam-susceptible phenotype, we have exam-
ined WTA from ECg-grown MRSA in relation to bacterial cell
morphology and surface charge properties.
Materials and methods
Bacterial strains and reagents
S. aureus BB568 (a homogeneous methicillin-resistant strain that
constitutively expresses PBP2a) was provided by B. Berger-Ba¨chi,
Institute of Medical Microbiology, University of Zu¨rich. The epi-
demic MRSA isolate EMRSA-16 was isolated from a clinical
sample at the Royal Free Hospital, London, UK. ECg was a gift
from Y. Hara, Mitsui Norin, Tokyo, Japan. Oxacillin was purchased
from Sigma-Aldrich. Bacteria were grown in Mueller–Hinton broth
(MHB; Oxoid). MICs were determined as described previously.4
Purification of peptidoglycan–WTA complexes
ECg was dissolved in 50% v/v ethanol and added to batches
(a series of 1–10 L batches were employed in order to accumulate
sufficient material for analyses) of MHB to give a final concen-
tration of 12.5 mg/L; the same volume (0.5 mL) of the vehicle was
added to control flasks. Cultures were incubated at 378C in an
orbital incubator (180 rpm) and harvested by centrifugation once the
OD660 had reached 0.6–0.7. Murein was prepared using a procedure
adapted from Strande´n et al.,16 cells were suspended in 10 mL of
2 M NaCl and disrupted with 0.1 mm sterilized glass beads using a
FastPrepw instrument (Qbiogene) for 45 s at speed setting 6. Cell
wall fragments were recovered by centrifugation (14100 g; 4 min),
the pellet suspended in phosphate-buffered saline (PBS) and the
glass beads allowed to settle to the bottom of the tube. Wall material
was washed three times with 30 mL of 0.5% w/v sodium dodecyl
sulphate and three times with water; it was then suspended in 30 mL
of water and incubated with gentle stirring at 608C for 30 min to
remove non-covalently bound components. Cell walls were recov-
ered by centrifugation, washed with 30 mL of water and covalently
bound protein A removed by incubation at 378C with 20 mL of
trypsin (0.2 mg/mL) in 0.15 mM Tris–HCl pH 7.0 for 18 h with
stirring. After recovery by centrifugation, wall material was washed
with 1 M Tris–HCl, 1 M Tris–HCl containing 1 M NaCl, again
with 1 M Tris–HCl (all pH 7.0) and three times with water.
Hydrolysis of peptidoglycan–WTA complexes
Teichoic acid was released from peptidoglycan–WTA using 10% w/v
aqueous trichloroacetic acid (TCA) at 48C for 18 h. Peptidoglycan was
removed by centrifugation (5526 g; 45 min; room temperature) and
WTA precipitated from the supernatant with 0.1 vol of 3 M sodium
acetate pH 5.1 in 3 vol of 95% ice-cold ethanol and held overnight at
2808C. After centrifugation (5526 g; 30 min; room temperature), the
pellet was washed five times with 95% ethanol; after the final ethanol
wash, the solvent was allowed to evaporate, purified WTAwas lyophi-
lized and stored at 2208C. The hydrolysis procedure released WTA in
its D-alanine (D-Ala)-substituted monomeric form.
Hydrolysis of peptidoglycan by lysostaphin
Purified peptidoglycan–WTA was suspended to OD600 0.5 in
50 mM Tris–HCl pH 7.5 containing 145 mM NaCl and 4 U lyso-
staphin (Sigma-Aldrich). The rate of hydrolysis was determined by
measuring reduction in OD600 during incubation at 378C. For the
determination of the rate of hydrolysis of peptidoglycan, WTA was
removed from samples with 10% v/v TCA at 48C for 24 h and
WTA-free peptidoglycan was recovered by centrifugation, followed
by washing with water.
Electron microscopy
For scanning electron microscopy (SEM), bacteria were recovered
by centrifugation and washed twice with PBS. Cells were fixed in
1.5% w/v glutaraldehyde for at least 2 h at room temperature,
washed once with 70% ethanol and twice with 100% ethanol.
Air-dried, gold-coated preparations were examined using an FEI
XL30 scanning electron microscope. For transmission electron
microscopy (TEM), recovered, PBS-washed cells were fixed in glu-
taraldehyde as before, treated with osmium tetroxide and embedded
in epoxy resin. Sectioning and staining with uranyl acetate were fol-
lowed by Reynolds’ lead citrate. Ultra-thin sections were viewed
and photographed using a Philips 201 transmission electron micro-
scope. Binding of cationized ferritin to the bacterial surface was
determined according to Graham and Beveridge17 using a final ferri-
tin concentration of 16.6 mg/L.
NMR spectroscopy
Samples (20 mg) were dissolved in 10% D2O–90% H2O. Spectra
were acquired at 298 K on a Bruker Avance NMR 500 MHz instru-
ment (Bruker BioSpin) equipped with gradients and broadband
probe. For structural elucidation, a set of 1D and 2D 1H, 31P and
13C experiments with solvent pre-saturation were undertaken.
Spectra were processed using Topspin 1.3 software (Bruker
BioSpin).
Molecular modelling
Modelling was undertaken using Maestro graphics interface
(Schro¨dinger LLC) and MacroModel 9.11;18 poses were energy-
minimized using the Merck molecular force field19 and the influence
of solvation free energy considered by the generalized Born/surface
area continuum model.20 Cut-off distances for non-bonded
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interactions were as follows: 8 A˚ for van der Waals, 20 A˚ for elec-
trostatic interactions and 4 A˚ for hydrogen bonding. Conformational
searches employed Monte Carlo torsional sampling (5000 steps) on
octomers; stochastic dynamic simulations on dodecamers were
carried out using an established protocol.21 Models obtained by
conformational searches and stochastic simulations were
complementary.
Results and discussion
ECg (12.5 mg/L) reduced the MIC of oxacillin for S. aureus
BB568 and EMRSA-16 from 256 and 512 mg/L, respectively, to
1 mg/L. Growth in the presence of ECg induced morphological
changes to strains EMRSA-16 and BB568. SEM of control cells
(Figure 1a) indicated typically round or ovoid, loosely clumped
cocci with smooth surfaces. In cells exposed to 12.5 mg/L ECg
(Figure 1b), larger, poorly separated bacteria with a rougher
surface were observed. Measurement using TEM of
glutaraldehyde-fixed cells, sectioned mid-line through the longi-
tudinal axis, determined the mean diameter of control cells to be
623+10 nm (SEM; n¼10) and diameters of the more hetero-
geneous ECg-grown cell population to range from 550 to
950 nm. TEM of sections indicated that growth in ECg increased
the thickness of the cell wall (Figure 1d) compared with control
bacteria (Figure 1c) and the cells tended to remain as ‘packets’
rather than separate cleanly. The outer layer of the wall of
ECg-grown cells was noticeably more fibrous in nature
(Figure 1d) than that of controls (Figure 1c).
Growth in MHB supplemented with 12.5 mg/L ECg mark-
edly decreased the susceptibility of MRSA strains BB568 and
EMRSA-16 to lysostaphin; for both strains, the lysostaphin MIC
was increased from 0.06 to .8 mg/L. Peptidoglycan–WTA
complexes extracted from BB568 cells grown in MHB
supplemented with 12.5 mg/L ECg were less susceptible to lyso-
staphin hydrolysis (24% hydrolysis in 50 min) than complexes
from bacteria grown in non-supplemented medium (50% in
50 min); following removal of WTA, both the rate and the
extent of peptidoglycan hydrolysis were indistinguishable
regardless of ECg supplementation of the growth medium.
Cultures of BB568 or EMRSA-16 yielded 0.2–3.0 mg of
WTA monomer per litre of broth culture, depending on the
strain and the presence or absence of ECg in the growth
medium. To obtain sufficient material for analysis by NMR,
material obtained from several 1–10 L batches of culture was
pooled prior to analysis. With NMR, structural assignment was
achieved by manual examination of 1H–1H, 1H–31P and
1H–13C correlations in 2D homonuclear (correlation spec-
troscopy) and 2D heteronuclear (heteronuclear single quantum
coherence, heteronuclear multiple quantum coherence and
heteronuclear multiple bond coherence) spectra. Full assignments
of all spectra were achieved, and the chemical shifts obtained
(Table 1) for the D-ribitol-5-phosphate and N-acetyl glucosamine
(GlcNAc) constituents were in good agreement with the known
assignments for monomers derived from the (1!5)-linked
poly(ribitol phosphate) WTA elaborated by S. aureus MN8m.22
The methyl group of D-Ala (d¼1.538) was clearly differentiated
from the methyl group of GlcNAc (Figure 3b; d¼2.006),
enabling quantification of the extent of D-Ala esterification of
the monomeric units (Figure 2a). D-Ala substitution also influ-
enced the resonant frequency of the 31P signal: d¼0.4 ppm for
D-Ala-esterified WTA and d¼1.1 ppm for non-esterified
monomer. The fully assigned spectra are presented as
Supplementary data [see Figure S1 available at JAC Online
(http://jac.oxfordjournals.org/)].
The molar ratios of constituent WTA monomer units were
determined by the comparison of the area under the peak of cor-
responding groups (Figure 2b). Thus, the ribitol phosphate
(a)
(c) (d)
(b)
2 m
500 nm 500 nm
2 m
Figure 1. SEM (a and b) and TEM (c and d) images of S. aureus EMRSA-16 grown to mid-logarithmic phase in the absence (a and c) and presence (b and
d) of 12.5 mg/L ECg. Essentially identical images were obtained using BB568.
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backbone units are universally glycosylated at position 4 but
variably substituted at C2 with D-Ala (Figure 2a). The ratios of
GlcNAc to D-Ala in WTA extracted from BB568 and EMRSA-16
grown in the absence of ECg were 0.6 and 0.49, respectively, as
indicated by 1H NMR (Table 2). When ECg (12.5 mg/L) was
incorporated into the MHB growth medium, the degree of
D-alanylation was significantly reduced to 0.3 for BB568 and 0.28
for EMRSA-16. The decreases in D-Ala content in response to
exposure to ECg were confirmed by 31P NMR (Table 2).
Changes in the degree of D-alanylation can have profound
effects on the conformation and charge characteristics of the sta-
phylococcal surface. The D-alanyl ester content of WTA is
highly variable and subject to modulation by environmental
influences such as pH, temperature and NaCl and Mg2þ concen-
trations.14 The amino group of D-Ala, with a predicted pKa of
8.42, is protonated at neutral pH, conferring a positive charge on
the D-Ala moiety. In this protonated state, the amino group has
the capacity to form ion pairs with phosphodiester either up or
down the chain,14 inducing two distinct energy-minimized con-
formational states. To examine the effect of different degrees of
D-Ala substitution on predicted WTA conformation, we carried
out in silico conformational searches and stochastic simulations
on octameric and dodecameric (1!5)-linked poly-D-ribitol-
phosphate-GlcNAc chains. The position of D-Ala residues along
the chain was randomized to reflect the even distribution of
esters in purified polymers.14 As anticipated, the charge distri-
bution on the chain surface was heavily influenced by D-Ala
content (Figure 3a). Chains with a GlcNAc-to-D-Ala ratio of 0.6,
simulating WTA extracted from BB568 grown in the absence of
ECg, displayed a mainly positively charged surface; these
charges corresponded to the amino groups of D-Ala. Negative
surfaces are more prominent on WTA from EMRSA-16 control
cells (0.49), whilst mainly negative surfaces can be observed in
chains with a ratio (0.3) simulating ECg-induced WTA.
Consistent with these predictions is the observation that
ECg-treated cells bound more cationized ferritin than controls
when examined by TEM (Figure 4). Modelling also indicated
that D-Ala might affect chain flexibility. The hydrogen bonds
that form between amine and phosphate groups14 decrease the
potential for free rotation within each unit, decreasing flexibility.
Our simulations (Figure 3b) indicate that such hydrogen bonding
results in the formation of an extended chain when the
GlcNAc:D-Ala ratio is 0.49, and an ECg-induced reduction to
0.3 results in increased chain flexibility, producing a random
coil conformation reminiscent of that proposed for WTA at high
ionic strength.23 Interestingly, modelling of WTA with a ratio of
0.6, corresponding to the polymer from BB568 control cells,
suggests that when the degree of D-Ala substitution is relatively
high, chains are inflexible but are not extended compared with
0.49 octomers, due to the constraints imposed by hydrogen
bonding between D-Ala residues and non-neighbouring phos-
phate groups, causing kinks in chain conformation (Figure 3b).
These changes in the conformation of WTA may explain
differences in the packing of EMRSA-16, BB568 and
ECg-treated cells: equivalent amounts of bacteria (mg of dry
weight) recovered from MHB occupy volumes corresponding to
the hydrodynamic volume of the cell wall predicted by our
simulations (data not shown).
Table 1. 1H, 13C and 31P chemical shifts (d ppm) of WTA from S. aureus BB568 and EMRSA-16a
Chemical shift (d ppm)
Unit/NMR type 1/10 2 3/30 4 5/50 6/60
Ribb
1H 3.9/4.05 3.83 3.84 4.068 3.87/4.071
13C 66.77 70.3 71.09 79.38 64.95
31P 1.1
b-GlcNAc
1H 4.65 3.68 3.486 3.381 3.38 3.66/3.83
13C 101.38 55.78 74.78 70.00 75.78 60.73
RibþD-Ala
1H 3.9/4.05 5.33 4.05 4.068 4.071
13C 66.7 74.78 66.77 79.38 64.95
31P 0.4
Ala
1H 4.18 1.538
13C 170.0 49.11 15.51
NAc
1H 2.006
13C 175.08 22.472
aThe 1D 1H spectrum with water was acquired using a sweep width of 10330 Hz and 65536 data points, giving 256 transients. The 1D 13C spectra were
acquired using a sweep width of 30030 Hz and 131072 data points, giving 26000 transients. The 2D HMQC (pulse program inv4gpqf) and HMBC (pulse
program inv4gplplrndqf) spectra were acquired with 1024 data points in direct dimensions (sweep width 4882 Hz) and 256 complex points (sweep width
31440).
bRib, ribitol; GlcNAc, N-acetyl glucosamine; D-Ala, D-alanine; NAc, N-acetyl.
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It is tempting to speculate that the conformational changes
induced by ECg are responsible for the observed decreases in
the susceptibility of peptidoglycan–WTA complexes to lyso-
staphin, with the random movement of the WTA chains restrict-
ing access of the enzyme to the pentaglycine cross-bridges.
Changes in chain conformation may also lead to different
packing arrangements for WTA within the cell wall, with our
data indicating that packing efficiency may be highest at a ratio
of 0.49 and lowest at 0.3, and that this may also impact on enzy-
matic hydrolysis. The main conclusion drawn from this study,
that growth in the presence of ECg produces large reductions in
D-alanylation of WTA, provides a rationale for some aspects of
the complex galloyl catechin-induced phenotype. For example,
dlt mutants of S. aureus, lacking the capacity to synthesize or
attach D-Ala esters to teichoic acids, lose their ability to form
biofilms on polystyrene or glass surfaces due to electrostatic
repulsion resulting from a stronger negative surface charge.24
Similarly, a reduction in D-alanylation is likely to account for
our observation12 that ECg elicits retention of autolysins within
the cell wall. There is good evidence14 that the number of
binding sites for autolysins within the cell wall is in part deter-
mined by the degree of D-alanylation of teichoic acids: these
enzymes require anionic sites for their retention, although the
role played by wall matrix charge characteristics in the modu-
lation of autolytic activity is less clear.
Reductions in D-alanylation are correlated with increases in
susceptibility to cationic antibacterial peptides25 and
glycopeptide antibiotics such as vancomycin,26 but the role of
D-Ala in modulating resistance to b-lactam agents, which are
anionic at physiological pH, is less well understood. dlt mutants
of Bacillus subtilis are more susceptible to methicillin than the
parent strain.15 However, Nakao et al.27 reported that insertional
mutagenesis of genes in the dlt operon of an S. aureus clinical
isolate with a relatively low level of methicillin resistance
(16 mg/L) resulted in a decrease in methicillin susceptibility,
although the authors did not demonstrate a reduction in
D-alanylation of teichoic acids. Our data tend to favour a role for
GlcNAc
2.2 2.0 1.8 1.6 1.4 2.2 2.0 1.8 1.6 1.4
–ECg +ECg
(ppm)
GlcNAcD-Ala D-Ala
3.0 1.5 3.0 0.8
(a)
HO
P
O
OH2C OH2C
CH2O CH2OH
GlcNAc GlcNAc
D-Ala
H
H
H
H
H
HOH
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O
O
OH
O
OH
Peak area
P
O
OH
(b)
Figure 2. Schematic structure of WTA: two units of the variable length (1!5)-linked poly-D-ribitol-phosphate-GlcNAc chain are shown, one substituted with
D-Ala at C2 of the ribitol moiety (a). 1H-NMR spectra show GlcNAc and D-Ala peaks of WTA extracted from non-treated cells and cells exposed to 12.5 mg/L
ECg (b).
Table 2. Ratio of D-Ala:GlcNAc in WTA from S. aureus BB568
and EMRSA-16 grown in the presence and absence of 12.5 mg/L
ECg
NMR type
Strain and treatment 1H 31P
BB568 0.6a
BB568þECg 0.3
EMRSA-16 0.49 (0.42–0.56) 0.6
EMRSA-16þECg 0.28 (0.26–0.30) 0.23
aFor 1H NMR spectra, D-Ala:GlcNAc ratios represent the mean of three
determinations (range).
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D-Ala in the modulation of b-lactam resistance, although it is
likely that the very large reductions in MIC that we observe can
only be explained by interruption of mecA-mediated resistance,
and it is at present unclear how D-alanylation of WTA can impact
on such a process. Thus, our current work could indicate that
PBP2a is only functional in the presence of teichoic acids that are
properly D-alanylated. However, the ionic charge imparted by tei-
choic acids influences the stability and folding of proteins in the
cell wall through modulation of divalent cation binding to tei-
choic acids.14 Further, teichoic acids may affect the phase tran-
sition profile of phospholipid bilayers, at least in model
systems.28 These events may impact on the function of membrane
and wall enzymes, such as PBP2a, involved in b-lactam resist-
ance and may compromise the capacity of PBPs to target the
septum during cell division, determining the ECg-induced pheno-
type. We are currently investigating the biophysical properties of
the cytoplasmic membrane from ECg-treated staphylococci in an
attempt to determine the relevance of such observations to the
modulation of b-lactam resistance.
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